Colorectal cancers of rare histologic types compared with adenocarcinomas

Dis Colon Rectum. 1994 Dec;37(12):1277-80. doi: 10.1007/BF02257796.

Abstract

Purpose: To examine clinical characteristics of colorectal cancers of rare histologic types compared with adenocarcinomas.

Methods: Review of a population-based registry with complete ascertainment.

Results: There were 7,422 colorectal cancers, 4,900 (66 percent) colonic and 2,522 (34 percent) rectal. Two hundred fifty-five cancers (3 percent) were of nonadenocarcinoma varieties including 75 (33 percent) squamous, 74 (33 percent) malignant carcinoids, 37 (16 percent) transitional cell-like, 25 (11 percent) lymphomas, 9 (4 percent) sarcomas, and 2 (0.9 percent) melanomas. Sixty (1.2 percent) of the colon cancers occurred in the appendix, and proportionately more carcinoids accounted for these tumors. Compared with adenocarcinomas, colonic and rectal carcinoids and colonic lymphomas accounted for a larger proportion of cancers in the younger age groups. The elderly had proportionately fewer colonic carcinoids. Colonic carcinoids, rectal squamous-cell cancers, and rectal transitional cell-like cancers were more common in women. Colonic lymphomas had a worse prognosis than adenocarcinomas. Survival was better with colonic and rectal carcinoids and rectal transitional cell-like cancers than with adenocarcinomas.

Conclusions: Colorectal cancers of histologic varieties other than adenocarcinoma have distinctive epidemiologic and clinical traits.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / epidemiology
  • Adult
  • Age Distribution
  • Aged
  • Carcinoid Tumor / epidemiology
  • Carcinoma, Squamous Cell / epidemiology
  • Carcinoma, Transitional Cell / epidemiology
  • Colorectal Neoplasms / epidemiology*
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / pathology*
  • Female
  • Humans
  • Lymphoma / epidemiology
  • Male
  • Melanoma / epidemiology
  • Middle Aged
  • Retrospective Studies
  • Sarcoma / epidemiology
  • Sex Distribution
  • Survival Rate